Cargando…

Which patients with heart failure should receive specialist palliative care?

AIMS: We investigated which patients with heart failure (HF) should receive specialist palliative care (SPC) by first creating a definition of need for SPC in patients hospitalised with HF using patient‐reported outcome measures (PROMs) and then testing this definition using the outcome of days aliv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Campbell, Ross T., Petrie, Mark C., Jackson, Colette E., Jhund, Pardeep S., Wright, Ann, Gardner, Roy S., Sonecki, Piotr, Pozzi, Andrea, McSkimming, Paula, McConnachie, Alex, Finlay, Fiona, Davidson, Patricia, Denvir, Martin A., Johnson, Miriam J., Hogg, Karen J., McMurray, John J.V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2018
Materias:	Treatment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6607479/ https://www.ncbi.nlm.nih.gov/pubmed/29952090 http://dx.doi.org/10.1002/ejhf.1240

Ejemplares similares

The feasibility of a randomised controlled trial to compare the cost-effectiveness of palliative cardiology or usual care in people with advanced heart failure: Two exploratory prospective cohorts
por: Johnson, Miriam J, et al.
Publicado: (2018)

Adverse Outcomes Associated With Interleukin-6 in Patients Recently Hospitalized for Heart Failure With Preserved Ejection Fraction
por: Mooney, Leanne, et al.
Publicado: (2023)

Palliative care needs in patients hospitalized with heart failure (PCHF) study: rationale and design
por: Campbell, Ross T., et al.
Publicado: (2015)

Rationale and methods of a randomized trial evaluating the effect of neprilysin inhibition on left ventricular remodelling
por: Docherty, Kieran F., et al.
Publicado: (2020)

Drug therapy for heart failure with reduced ejection fraction: what is the ‘right’ dose?
por: Kondo, Toru, et al.
Publicado: (2022)

Efficacy of implantable haemodynamic monitoring in heart failure across ranges of ejection fraction: a systematic review and meta-analysis
por: Curtain, James P, et al.
Publicado: (2023)

Resistance to antihypertensive treatment and long‐term risk: The Atherosclerosis Risk in Communities study
por: Wijkman, Magnus O., et al.
Publicado: (2021)

Treatment of Type 2 Diabetes and Outcomes in Patients With Heart Failure: A Nested Case–Control Study From the U.K. General Practice Research Database
por: MacDonald, Michael R., et al.
Publicado: (2010)

The neprilysin pathway in heart failure: a review and guide on the use of sacubitril/valsartan
por: Jhund, Pardeep S, et al.
Publicado: (2016)

Dapagliflozin reduces uric acid concentration, an independent predictor of adverse outcomes in DAPA‐HF
por: McDowell, Kirsty, et al.
Publicado: (2022)

Association is not causation: treatment effects cannot be estimated from observational data in heart failure
por: Rush, Christopher J, et al.
Publicado: (2018)

Cost‐effectiveness of dapagliflozin as a treatment for heart failure with reduced ejection fraction: a multinational health‐economic analysis of DAPA‐HF
por: McEwan, Phil, et al.
Publicado: (2020)

Baseline characteristics and treatment of patients in Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF)
por: McMurray, John J V, et al.
Publicado: (2014)

Comparing uptake across breast, cervical and bowel screening at an individual level: a retrospective cohort study
por: McCowan, Colin, et al.
Publicado: (2019)

Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM‐HF trial
por: Vardeny, Orly, et al.
Publicado: (2016)

Effect of Neprilysin Inhibition on Left Ventricular Remodeling in Patients With Asymptomatic Left Ventricular Systolic Dysfunction Late After Myocardial Infarction
por: Docherty, Kieran F., et al.
Publicado: (2021)

Four-Coordinate Fe N(2) and Imido Complexes Supported by a Hemilabile NNC Heteroscorpionate Ligand
por: McSkimming, Alex, et al.
Publicado: (2022)

Mineralocorticoid Receptor Antagonists, Blood Pressure, and Outcomes in Heart Failure With Reduced Ejection Fraction
por: Serenelli, Matteo, et al.
Publicado: (2020)

Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction
por: Rørth, Rasmus, et al.
Publicado: (2019)

The novel urinary proteomic classifier HF1 has similar diagnostic and prognostic utility to BNP in heart failure
por: Campbell, Ross T., et al.
Publicado: (2020)

Classifying kinase conformations using a machine learning approach
por: McSkimming, Daniel Ian, et al.
Publicado: (2017)

Palliative treatment of uncontrollable hypercalcemia due to parathyrotoxicosis: denosumab as rescue therapy
por: Jumpertz von Schwartzenberg, Reiner, et al.
Publicado: (2015)

What can we learn from RELAX-AHF compared to previous AHF trials and what does the future hold?
por: Cannon, Jane A, et al.
Publicado: (2015)

Within trial comparison of survival time projections from short‐term follow‐up with long‐term follow‐up findings
por: Ferreira, João Pedro, et al.
Publicado: (2022)

Initiating sacubitril/valsartan (LCZ696) in heart failure: results of TITRATION, a double‐blind, randomized comparison of two uptitration regimens
por: Senni, Michele, et al.
Publicado: (2016)

Laxatives Do Not Improve Symptoms of Opioid-Induced Constipation: Results of a Patient Survey
por: Emmanuel, Anton, et al.
Publicado: (2017)

Assembly and Redox-Rich Hydride Chemistry of an Asymmetric Mo(2)S(2) Platform
por: McSkimming, Alex, et al.
Publicado: (2020)

Estimating the Lifetime Benefits of Treatments for Heart Failure
por: Ferreira, João Pedro, et al.
Publicado: (2020)

The Dapagliflozin and Prevention of Adverse outcomes in Heart Failure trial (DAPA-HF) in context
por: McMurray, John J V, et al.
Publicado: (2020)

Development of a Psychologically Enhanced Interactive Online Intervention for Hazardous Drinking
por: Linke, Stuart, et al.
Publicado: (2008)

Initiation of domiciliary care and nursing home admission following first hospitalization of heart failure patients: a nationwide cohort study
por: Rørth, Rasmus, et al.
Publicado: (2018)

Megaselia steptoeae (Diptera: Phoridae): specialists on smashed snails
por: Brown, Brian V., et al.
Publicado: (2020)

Effect of Empagliflozin on Left Ventricular Volumes in Patients With Type 2 Diabetes, or Prediabetes, and Heart Failure With Reduced Ejection Fraction (SUGAR-DM-HF)
por: Lee, Matthew M.Y., et al.
Publicado: (2020)

Waiting for JAK inhibitor safety data
por: Kragstrup, Tue Wenzel, et al.
Publicado: (2022)

Talking to patients with heart failure about end of life
por: Campbell, Ross T., et al.
Publicado: (2018)

JAK inhibitors disrupt T cell-induced proinflammatory macrophage activation
por: Nyirenda, Mukanthu H, et al.
Publicado: (2023)

COVID-19 and Hospital Palliative Care – A service evaluation exploring the symptoms and outcomes of 186 patients and the impact of the pandemic on specialist Hospital Palliative Care
por: Hetherington, Lucy, et al.
Publicado: (2020)

Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS‐9) in heart failure patients: results from a phase 3 randomized, double‐blind, placebo‐controlled trial
por: Anker, Stefan D., et al.
Publicado: (2015)

Satisfaction, Adherence and Health-Related Quality of Life with Transdermal Buprenorphine Compared with Oral Opioid Medications in the Usual Care of Osteoarthritis Pain
por: Conaghan, Philip G., et al.
Publicado: (2016)

CO(2) reduction with protons and electrons at a boron-based reaction center
por: Taylor, Jordan W., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_po2vbhc9ngm85bmnbv5vn3sopd